Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2024 results , with sales up 14.6% year on year to ...

Mizuho raised the firm’s price target on Quest Diagnostics (DGX) to $178 from $177 and keeps an Outperform rating on the shares following the ...

Piper Sandler analyst David Westenberg raised the firm’s price target on Quest Diagnostics (DGX) to $180 from $165 and keeps a Neutral rating ...

Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

On a per-share basis, the Secaucus, New Jersey-based company said it had profit of $1.95. Earnings, adjusted for one-time gains and costs, came to $2.23 per share. The results exceeded Wall Street ...

Laboratory operator Quest Diagnostics beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by a robust appetite for its diagnostic tests.

The Unit examines other countries’ business environments and their historical development. The BGIE group is deeply interested in the impact of globalization and the way rules are emerging to govern ...

Bengaluru (Karnataka) [India], January 16: Bengaluru-based biotechnology startup, CrisprBits Private Limited, has inaugurated a CRISPR gene editing and diagnostics laboratory in Bengaluru. The new ...

Neuberg Diagnostics has secured an investment of Rs 940 crores from Kotak Alt in the primary fund-raise. Speaking about the fundraise, Dr GSK Velu, Founder and MD of Neuberg Diagnostics, said, “We are ...